Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: A double-blind randomized controlled trial

American Journal of Clinical Nutrition

Volumn 97, Issue 5, 2013, Pages 936-942

  Curtis, Peter J ^a   Potter, John ^a   Kroon, Paul A ^b   Wilson, Paddy ^c   Dhatariya, Ketan ^c   Sampson, Mike ^c   Cassidy, Aedín ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVAN 3 OL; FLAVONOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOFLAVONE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BLOOD VESSEL FUNCTION; CACAO; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL;

AGED; ARTERIAL PRESSURE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; DIABETES MELLITUS, TYPE 2; DIET; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISOFLAVONES; MIDDLE AGED; PATIENT COMPLIANCE; POSTMENOPAUSE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84876915903     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.043745     Document Type: Article

References (42)

1. International Diabetes Federation. IDF diabetes atlas. 4th ed. Brussels, Belgium: International Diabetes Federation, 2009.
2. Jansson SP, Andersson DK, Svardsudd K. Mortality trends in subjects with and without diabetes during 33 years of follow-up. Diabetes Care 2010;33(3):551-6.
3. Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, Agudo-Conde C, Gomez-Sanchez L, Rodriguez-Sanchez E, Martin-Cantera C, Garcia-Ortiz L. Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series report. Cardiovasc Diabetol 2011;10(1):3.
4. Maffei E, Seitun S, Nieman K, Martini C, Guaricci AI, Tedeschi C, Weustink AC, Mollet NR, Berti E, Grilli R, et al. Assessment of coronary artery disease and calcified coronary plaque burden by computed tomography in patients with and without diabetes mellitus. Eur Radiol 2011;21:944-53.
5. Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011;34 (suppl): 285S-90S. 6. Takeno K, Mita T, Nakayama S, Goto H, Komiya K, Abe H, Ikeda F, Shimizu T, Kanazawa A, Hirose T, Kawamori R, Watada H. Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens 2012;25(2):165-70.
6. Scott R, Donoghoe M, Watts GF, O'Brien R, Pardy C, Taskinen MR, Davis TM, Colman PG, Manning P, Fulcher G, Keech AC; FIELD Study Investigators. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial. Cardiovasc Diabetol 2011;10(1):102.
7. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J,Westendorp RG, de Craen AJ, Knopp RH, Nakamura H, Ridker P, van Domburg R, Deckers JW. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009;338:b2376.
8. Mursu J, Nurmi T, Tuomainen TP, Ruusunen A, Salonen JT, Voutilainen S. The intake of flavonoids and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 2007; 98(4):814-8.
9. Djousse L, Hopkins PN, Arnett DK, Pankow JS, Borecki I, North KE, Curtis Ellison R. Chocolate consumption is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the NHLBI Family Heart Study. Clin Nutr 2011;30(1):38-43.
10. Hodis HN, Mack WJ, Kono N, Azen SP, Shoupe D, Hwang-Levine J, Petitti D, Whitfield-Maxwell L, Yan M, Franke AA, Selzer RH. Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Stroke 2011;42(11):3168-75.
11. Schewe T, Steffen Y, Sies H. How do dietary flavanols improve vascular functioň A position paper. Arch Biochem Biophys 2008;476:102-6.
12. Gomez-Guzman M, Jimenez R, Sanchez M, Zarzuelo MJ, Galindo P, Quintela AM, Lopez-Sepulveda R, Romero M, Tamargo J, Vargas F, Perez-Vizcaino F, Duarte J. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic Biol Med 2012;52(1):70-9.
13. Babu PV, Si H, Fu Z, Zhen W, Liu D. Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice. J Nutr 2012;142(4): 724-30.
14. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008;88:38-50.
15. Pase MP, Grima NA, Sarris J. The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am J Clin Nutr 2011;93(2):446-54.
16. Taku K, Lin N, Cai D, Hu J, Zhao X, Zhang Y, Wang P, Melby MK, Hooper L, Kurzer MS, et al. Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebo-controlled trials. J Hypertens 2010;28:1971-82.
17. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007;50(1):197-203.
18. Clerici C, Nardi E, Battezzati PM, Asciutti S, Castellani D, Corazzi N, Giuliano V, Gizzi S, Perriello G, Di Matteo G, Galli F, Setchell KD. Novel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes. Diabetes Care 2011;34(9):1946-8.
19. Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, Merx M, Heussen N, Gross HB, Keen CL, Schroeter H, Kelm M. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 2008;51 (22):2141-9.
20. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002; 25:1709-14.
21. Mellor DD, Sathyapalan T, Kilpatrick ES, Beckett S, Atkin SL. Highcocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients. Diabet Med 2010;27:1318-21.
22. Jackman KA, Woodman OL, Chrissobolis S, Sobey CG. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries. Brain Res 2007;1141:99-107.
23. Joy S, Siow RC, Rowlands DJ, Becker M, Wyatt AW, Aaronson PI, Coen CW, Kallo I, Jacob R, Mann GE. The isoflavone equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J Biol Chem 2006;281(37):27335-45.
24. Clerici C, Setchell KD, Battezzati PM, Pirro M, Giuliano V, Asciutti S, Castellani D, Nardi E, Sabatino G, Orlandi S, Baldoni M, Morelli O, Mannarino E, Morelli A. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr 2007;137(10):2270-8.
25. Curtis PJ, Sampson M, Potter J, Dhatariya K, Kroon PA, Cassidy A. Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, doubleblind, randomized, controlled trial. Diabetes Care 2012;35(2):226-32.
26. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005;81(suppl):243S-55S.
27. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, Ikonomidis I, Kotsis V, Spiliopoulou I, Vemmos K, Mavrikakis M, Moulopoulos SD. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005;45(4):505-12.
28. Polak JF, Pencina MJ, O'Leary DH, D'Agostino RB. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke 2011;42(11):3017-21.
29. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55(13): 1318-27.
30. Zhang M, Bai Y, Ye P, Luo L, Xiao W, Wu H, Liu D. Type 2 diabetes is associated with increased pulse wave velocity measured at different sites of the arterial system but not augmentation index in a Chinese population. Clin Cardiol 2011;34:622-7.
31. Blacher J, Protogerou AD, Henry O, Czernichow S, Iaria P, Zhang Y, Agnoletti D, Safar ME. Aortic stiffness, inflammation, denutrition and type 2 diabetes in the elderly. Diabetes Metab 2012;38(1):68-75.
32. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001;86:3053-60.
33. Zhang B, Chen YM, Huang LL, Zhou XX, Chen CG, Ye YB, Su YX. Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults. Atherosclerosis 2008;198(2):403-11.
34. Du JL, Liu JF, Men LL, Yao JJ, Sun PL, Sun GH, Song GR, Yang Y, Bai R, Xing Q, et al. Effects of five-year intensive multifactorial intervention on the serum amyloid A and macroangiopathy in patients with short-duration type 2 diabetes mellitus. Chin Med J (Engl) 2009; 122:2560-6.
35. Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 2011;365:2078-87.
36. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, Cockcroft JR, Wilkinson IB. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 2008;51(6):1476-82.
37. Stamatelopoulos KS, Manios E, Barlas G, Koroboki E, Zacharoulis A, Tsivgoulis G, Kollias G, Kyrkou K, Tsigas N, Papamichael C, et al. Time rate of blood pressure variation is superior to central hemodynamics as an associate of carotid intima-media thickness. J Hypertens 2010;28:51-8.
38. Montenegro MF, Pessa LR, Tanus-Santos JE. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. Eur J Pharmacol 2009;607: 173-7.
39. Duncan RE, El-Sohemy A, Archer MC. Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin. Cancer Lett 2005;224:221-8.
40. Giroux I, Lavigne C, Moorjani S, Jacques H. Simvastatin further enhances the hypocholesterolemic effect of soy protein in rabbits. J Am Coll Nutr 1997;16:166-74.
41. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med 2007;43:645-57.
42. Hong KW, Ko KP, Ahn Y, Kim CS, Park SJ, Kim SS, Kim Y. Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype. Genes Nutr. 2012;7:567-74.